Skip to product search
DISCOUNT ON

Starvog 0.2 Tab

Voglibose (0.2mg)

10 TABLETProduct code 241491

YOUR PURCHASE PRICE

11 in stock
₹35.91MRP ₹47.7624.81% off

Inclusive of all taxes

Available batch

1 offer
Delivery from your selected hubPCMC

Sign in to order for your pharmacy.

Product information

Manufacturer
Merck Ltd
Category
Allopathy
Composition
Voglibose (0.2mg)
Packaging
10 TABLET
Box / case pack
1 / —
Description

STARVOG 0.2 Tablet

STARVOG 0.2 Tablet, manufactured by MERCK LTD, is an oral anti-diabetic medication used in the management of Type 2 Diabetes Mellitus.

  • Name:

    • Brand Name: STARVOG 0.2 Tablet
    • Common Name: Voglibose
  • Composition:

    • Each tablet contains Voglibose 0.2 mg as the active ingredient.
  • Uses: STARVOG 0.2 Tablet is prescribed for the treatment of Type 2 Diabetes Mellitus. It is used when diet and exercise alone are insufficient to control blood sugar levels. The medicine works by inhibiting intestinal enzymes responsible for breaking down complex carbohydrates into simple sugars, thereby delaying glucose absorption and preventing a rapid rise in blood sugar levels immediately after meals. It can be used as a standalone therapy or in combination with other oral anti-diabetic agents or insulin preparations to achieve better glycemic control.

  • Dosage and Administration:

    • STARVOG 0.2 Tablet should be taken orally just before each main meal as advised by a healthcare professional.
    • The typical adult dosage is 0.2 mg three times a day. Your doctor may adjust the dose up to 0.3 mg three times daily, with a maximum recommended daily dose of 0.6 mg, depending on your condition and response to treatment.
    • The tablet can be swallowed whole with water. If it is a mouth-dissolving tablet, allow it to dissolve in the mouth; do not crush or chew.
    • Do not skip doses or stop taking the medicine suddenly without consulting your doctor, as this may lead to increased blood glucose levels.
  • Side Effects:

    • Common Side Effects: Abdominal pain, diarrhoea, flatulence (gas), nausea, vomiting, heartburn, and skin reactions. Some patients may also experience constipation or abdominal fullness. These side effects are generally temporary and tend to resolve over time.
    • Consult your doctor if any of these side effects persist or worsen.
  • Precautions:

    • Allergies: Do not take STARVOG 0.2 Tablet if you are allergic to Voglibose or any of its components.
    • Medical Conditions: Inform your doctor if you have diabetic ketoacidosis, inflammatory bowel disease (IBD), intestinal ulcers, partial intestinal obstruction, digestion or absorption disorders, severe kidney problems, or severe liver problems.
    • Pregnancy and Breastfeeding: The safety of STARVOG 0.2 Tablet during pregnancy and breastfeeding is not well-established. Consult your doctor before using this medicine if you are pregnant or breastfeeding.
    • Children: Not recommended for use in children under 18 years of age unless specifically prescribed by a doctor, as safety and efficacy data are not available.
    • Alcohol Consumption: Avoid consuming alcohol while taking this medicine, as it can alter blood sugar levels and may increase the risk of side effects.
    • Drug Interactions: Inform your doctor about all other medicines, supplements, or herbal products you are currently taking to avoid potential interactions. Caution is advised when used with insulin, insulin secretagogues (e.g., glimepiride, gliclazide), digestive enzyme preparations, beta-blockers, keratolytics, MAOIs, anti-lipedmic agents, sympathomimetics, adrenocorticotropic hormones, and thyroid hormones.
    • Driving and Operating Machinery: Be cautious when driving or operating machinery, as fluctuations in blood sugar levels (very low or high) can cause dizziness, drowsiness, or visual disturbances.
  • Storage:

    • Store STARVOG 0.2 Tablet in a cool and dry place, protected from direct sunlight and moisture.
    • Maintain storage temperatures between 10ºC to 25ºC or below 30ºC.
    • Keep the medicine out of the sight and reach of children.
Frequently asked questions

STARVOG 0.2 TAB contains Voglibose, an alpha-glucosidase inhibitor primarily used in the management of type 2 diabetes mellitus. Here are some frequently asked questions about STARVOG 0.2 TAB:

What is STARVOG 0.2 TAB used for?

STARVOG 0.2 TAB is primarily used to treat type 2 diabetes mellitus, particularly to manage elevated blood sugar levels after meals (postprandial hyperglycemia). It is often prescribed when diet and exercise alone are insufficient to control blood sugar, or in combination with other anti-diabetic medications.

How does STARVOG 0.2 TAB work?

STARVOG 0.2 TAB contains Voglibose, which is an alpha-glucosidase inhibitor. It works by inhibiting enzymes in the small intestine that are responsible for breaking down complex carbohydrates into simpler sugars like glucose. This action slows down the digestion and absorption of carbohydrates, thereby preventing a rapid increase in blood sugar levels immediately after meals.

What is the usual dosage of STARVOG 0.2 TAB?

The typical adult dosage of STARVOG 0.2 TAB is 0.2 mg taken orally three times a day, immediately before each meal. Your doctor may adjust the dose based on your response to treatment and the severity of your diabetes, with a maximum recommended daily dose usually not exceeding 0.6 mg. It should be swallowed whole with water; do not crush or chew it.

What are the possible side effects of STARVOG 0.2 TAB?

Common side effects associated with STARVOG 0.2 TAB (Voglibose) are mainly gastrointestinal and include abdominal pain, diarrhea, flatulence (gas), heartburn, nausea, and vomiting. These side effects often decrease with continued therapy. In some cases, a rise in liver enzymes has been observed. If taken with other anti-diabetic medicines, it may increase the risk of low blood sugar levels (hypoglycemia). Consult your doctor if side effects persist or worsen.

Is STARVOG 0.2 TAB safe during pregnancy or breastfeeding?

The safety of Voglibose during pregnancy and breastfeeding has not been well-established. It is generally not recommended during these periods unless specifically advised by a doctor, who will weigh the potential benefits against the risks. If you are pregnant, planning to become pregnant, or breastfeeding, it is crucial to consult your doctor before taking this medication.

Can STARVOG 0.2 TAB be taken with other medications?

STARVOG 0.2 TAB can interact with other medications. Taking it with other anti-diabetic medications (like insulin or sulfonylureas) may increase the risk of low blood sugar (hypoglycemia). Digestive enzyme supplements may reduce its effectiveness. It's essential to inform your doctor about all medicines, supplements, or herbal remedies you are currently taking to prevent harmful interactions.

What precautions should be taken while using STARVOG 0.2 TAB?

Precautions should be taken if you have gastrointestinal disorders such as inflammatory bowel disease, intestinal ulcers, partial intestinal obstruction, or conditions that may worsen due to increased intestinal gas. It should be used with caution in patients with kidney or liver problems, as dose adjustment may be needed, and there's a risk of liver toxicity. Avoid alcohol consumption, as it may increase the risk of side effects. The use of Voglibose tablets should be limited to patients with established diabetes.

What happens if a dose of STARVOG 0.2 TAB is missed?

If you miss a dose of STARVOG 0.2 TAB, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one, as this can lead to adverse side effects.

How should STARVOG 0.2 TAB be stored?

STARVOG 0.2 TAB should be stored in a cool and dry place, away from direct sunlight, moisture, and heat. Keep the medication in its original packaging and out of reach of children and pets. Recommended storage temperatures are typically at room temperature (20°C to 25°C / 68°F to 77°F) or below 30°C.